GS
Gurubachan Singh Badesha
About Gurubachan Singh Badesha
Data last updated:
Gurubachan Singh Badesha has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Chhattisgarh Medical Services Corporation Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Chhattisgarh Medical Services Corporation Limited at ₹305 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Oct 2010 | 2010 | ₹305 Cr (FY 2019) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gurubachan Singh Badesha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurubachan Singh Badesha
Gurubachan Singh Badesha has 16 years in corporate governance. Holds Director role. Currently with 1 company, including Chhattisgarh Medical Services Corporation Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Chhattisgarh Medical Services Corporation Limited at ₹305 Cr (FY 2019).
Gurubachan Singh Badesha is associated with 1 company as Director, including Chhattisgarh Medical Services Corporation Limited (₹305 Cr).
Gurubachan Singh Badesha has expertise in General Business.
Gurubachan Singh Badesha has 16 years in corporate governance.
By reported revenue, the largest current company of Gurubachan Singh Badesha is Chhattisgarh Medical Services Corporation Limited, with revenue of ₹305 Cr (FY 2019).
Gurubachan Singh Badesha currently holds positions at 1 company: Chhattisgarh Medical Services Corporation Limited (₹305 Cr).